The Board granted service connection for peripheral neuropathy of the right hand and left foot, finding a relationship to chemotherapy received for Non-Hodgkins lymphoma.
The deciding factor: The decision was based on the Veteran's diagnosis of peripheral neuropathy related to chemotherapy treatment for his service-connected Non-Hodgkins lymphoma.
- Claimed conditions
- Peripheral neuropathy of the right hand, Peripheral neuropathy of the left foot
- How they argued it
- Secondary to another service-connected condition
- Exposure basis
- None
- Rating assigned
- 100%
- Decision date
- January 6, 2022
- Citation
- 22000810
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Granted
The Board granted an effective date of December 7, 2021, for the award of TDIU and DEA benefits.
- Granted
The Board granted service connection for a heart disability, MGUS, asymptomatic multiple myeloma, smoldering multiple myeloma, and peripheral neuropathy of the bilateral hands, forearms, lower legs, and feet based on toxic exposure risk activities during active service.
- Denied
The Board denied the claims for service connection for peripheral neuropathy of both feet and dismissed the TDIU claim as moot due to a previous grant.
- Granted
The Board granted a disability rating of 40 percent for the Veteran's left hand peripheral neuropathy and 30 percent for his right hand peripheral neuropathy, effective February 9, 2024.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.